We are live on ! Find out more
ACBI

Atlantic Capital Bancshares, Inc. Common Stock

Delisted

ACBI was delisted on the 28th of February, 2022.

0 hedge funds and large institutions have $0 invested in Atlantic Capital Bancshares, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 115 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 1160 (-116)

100% less funds holding in top 10

Funds holding in top 10: 20 (-2)

100% less capital invested

Capital invested by funds: $464M → $0 (-$464M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 115

Holders
Holders Change
-116
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
Reduced
Closed
115
Calls
Puts
Net Calls
Net Calls Change

ACBI Hedge Fund Activity: Q1 2022 in Review

0 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Atlantic Capital Bancshares, Inc. Common Stock (ACBI) for Q1 2022, worth a combined $0 — down 100% from $464M a quarter earlier.

Sellers outnumbered buyers: 115 funds closed out of ACBI and 0 opened new positions — a net loss of 115 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $76.8M sold.

  • 0 institutional investors held Atlantic Capital Bancshares, Inc. Common Stock (ACBI) as of Q1 2022, down from 116 in Q4 2021.
  • Funds reported $0 of Atlantic Capital Bancshares, Inc. Common Stock stock for Q1 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Atlantic Capital Bancshares, Inc. Common Stock positions in Q1 2022 and 115 closed out, a net change of -115 holders.
  • The largest Atlantic Capital Bancshares, Inc. Common Stock seller in Q1 2022 was T. Rowe Price Associates, an estimated $76.8M sold.

Based on aggregated 13F filings for Q1 2022.